The RNA expression analysis indicates that our ex vivo gene-editing approaches using Hpd-CRISPR-Cas9 ameliorated oxidative stress and protected against the induction of HCC markers in Fah−/− mice. The gene discussed is FAH; the disease is hepatocellular carcinoma.